Ingenza Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Private

  • Employees
  • 48

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 6

Ingenza General Information

Description

Operator of a biotechnology company intended to generate innovative biobased systems for a diverse range of customer problems. The company's services provide efficient, scalable bioprocesses for the manufacture of chemicals, biologics, pharmaceuticals, and biofuels, from sustainable sources, and have assembled integrated teams of scientists bringing together expertise across synthetic chemistry, informatics, molecular genetics, biochemistry, and fermentation scale-up, enabling clients to shorten the bioengineering design and test cycle and successfully construct bioprocesses.

Contact Information

Website
www.ingenza.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Moubray Building Edinburgh Technopole
  • Milton Bridge
  • Penicuik EH26 0GB
  • Scotland, United Kingdom
+44 01968
Primary Industry
Other Pharmaceuticals and Biotechnology
Corporate Office
  • Moubray Building Edinburgh Technopole
  • Milton Bridge
  • Penicuik EH26 0GB
  • Scotland, United Kingdom
+44 01968

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ingenza Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Later Stage VC 01-Jan-2025 Completed Generating Revenue
11. Grant 25-Apr-2024 Completed Generating Revenue
10. Grant 01-Oct-2022 Completed Generating Revenue
9. Grant 01-Mar-2021 Completed Generating Revenue
8. Grant 01-May-2020 Completed Generating Revenue
7. Grant 01-Jul-2019 Completed Generating Revenue
6. Grant 04-Jul-2017 Completed Generating Revenue
5. Grant 16-Aug-2016 Completed Generating Revenue
4. Grant 15-Feb-2016 $1.44M Completed Generating Revenue
3. Grant 06-Apr-2006 $174K Completed Generating Revenue
To view Ingenza’s complete valuation and funding history, request access »

Ingenza Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology company intended to generate innovative biobased systems for a diverse range of customer pro
Other Pharmaceuticals and Biotechnology
Penicuik, United Kingdom
48 As of 2025

Mountain View, CA
 

San Jose, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ingenza Competitors (29)

One of Ingenza’s 29 competitors is Cellecta, a Private Debt Financed company based in Mountain View, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cellecta Private Debt Financed Mountain View, CA
Molecular Devices Corporate Backed or Acquired San Jose, CA
Arzeda Venture Capital-Backed Seattle, WA
Codexis Formerly VC-backed Redwood City, CA
Spiber Venture Capital-Backed Stockholm, Sweden
You’re viewing 5 of 29 competitors. Get the full list »

Ingenza Patents

Ingenza Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4294438-A1 Endotoxin-free production of recombinant subunit vaccine components Pending 18-Feb-2021
GB-202314088-D0 Endotoxin-free production of recombinant subunit vaccine components Pending 18-Feb-2021
GB-2619239-A Endotoxin-free production of recombinant subunit vaccine components Pending 18-Feb-2021
US-20220282264-A1 Endotoxin-free production of recombinant subunit vaccine components Inactive 18-Feb-2021
WO-2022175871-A1 Endotoxin-free production of recombinant subunit vaccine components Inactive 18-Feb-2021 C12N15/75
To view Ingenza’s complete patent history, request access »

Ingenza Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ingenza Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
The FSE Group Venture Capital Minority
Horizon 2020 Government
Innovate UK Government
Scottish Enterprise Growth/Expansion
The University of Edinburgh University
You’re viewing 5 of 6 investors. Get the full list »

Ingenza Investments (6)

Ingenza’s most recent deal was a Later Stage VC with ProFactor Pharma for . The deal was made on 30-Sep-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
ProFactor Pharma 30-Sep-2022 Later Stage VC Drug Discovery
Amprologix 20-Sep-2018 Corporate Drug Discovery
ProFactor Pharma 16-Sep-2016 Later Stage VC Drug Discovery
ProFactor Pharma 31-Mar-2015 Later Stage VC Drug Discovery
ProFactor Pharma 20-Aug-2013 Seed Round Drug Discovery
You’re viewing 5 of 6 investments. Get the full list »

Ingenza FAQs

  • When was Ingenza founded?

    Ingenza was founded in 2002.

  • Where is Ingenza headquartered?

    Ingenza is headquartered in Penicuik, United Kingdom.

  • What is the size of Ingenza?

    Ingenza has 48 total employees.

  • What industry is Ingenza in?

    Ingenza’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Ingenza a private or public company?

    Ingenza is a Private company.

  • What is Ingenza’s current revenue?

    The current revenue for Ingenza is .

  • Who are Ingenza’s investors?

    The FSE Group, Horizon 2020, Innovate UK, Scottish Enterprise, and The University of Edinburgh are 5 of 6 investors who have invested in Ingenza.

  • Who are Ingenza’s competitors?

    Cellecta, Molecular Devices, Arzeda, Codexis, and Spiber are some of the 29 competitors of Ingenza.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process